These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9511045)

  • 41. Mechanisms accounting for fluoroquinolone multidrug resistance Escherichia coli isolated from companion animals.
    Liu X; Boothe DM; Thungrat K; Aly S
    Vet Microbiol; 2012 Dec; 161(1-2):159-68. PubMed ID: 22877517
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of fluoroquinolone resistance mechanisms and their correlation with the degree of resistance to clinically used fluoroquinolones among Escherichia coli isolates.
    Chang TM; Lu PL; Li HH; Chang CY; Chen TC; Chang LL
    J Chemother; 2007 Oct; 19(5):488-94. PubMed ID: 18073146
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
    Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
    Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antimicrobial activity of a new fluoroquinolone, DU-6859a, against quinolone-resistant clinical isolates of Neisseria gonorrhoeae with genetic alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV.
    Deguchi T; Yasuda M; Nakano M; Kanematsu E; Ozeki S; Ishihara S; Saito I; Kawada Y
    J Antimicrob Chemother; 1997 Feb; 39(2):247-9. PubMed ID: 9069547
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
    Bolon MK; Wright SB; Gold HS; Carmeli Y
    Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does mutation in gyrA and/or parC or efflux pump expression play the main role in fluoroquinolone resistance in Escherichia coli urinary tract infections?: A statistical analysis study.
    Shigemura K; Tanaka K; Yamamichi F; Shirakawa T; Miyake H; Fujisawa M
    Int J Antimicrob Agents; 2012 Dec; 40(6):516-20. PubMed ID: 23068598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.
    Oethinger M; Conrad S; Kaifel K; Cometta A; Bille J; Klotz G; Glauser MP; Marre R; Kern WV
    Antimicrob Agents Chemother; 1996 Feb; 40(2):387-92. PubMed ID: 8834885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium.
    Gensberg K; Jin YF; Piddock LJ
    FEMS Microbiol Lett; 1995 Oct; 132(1-2):57-60. PubMed ID: 7590165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
    Hwang TJ; Hooper DC
    J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853
    [No Abstract]   [Full Text] [Related]  

  • 50. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
    Xia P; Feng P; Zhong L; Lu X; Lei B
    Chin Med J (Engl); 2002 Jan; 115(1):31-5. PubMed ID: 11930654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J; Robicsek A; Hooper DC
    Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A survey of plasmid-mediated fluoroquinolone resistance genes from Escherichia coli isolates and their dissemination in Shandong, China.
    Xia LN; Li L; Wu CM; Liu YQ; Tao XQ; Dai L; Qi YH; Lu LM; Shen JZ
    Foodborne Pathog Dis; 2010 Feb; 7(2):207-15. PubMed ID: 19911944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamase.
    Poirel L; Pitout JD; Calvo L; Rodriguez-Martinez JM; Church D; Nordmann P
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1525-7. PubMed ID: 16569874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The region of the parE gene, homologous to the quinolone-resistant determining region of the gyrB gene, is not linked with the acquisition of quinolone resistance in Escherichia coli clinical isolates.
    Ruiz J; Casellas S; Jimenez de Anta MT; Vila J
    J Antimicrob Chemother; 1997 Jun; 39(6):839-40. PubMed ID: 9222061
    [No Abstract]   [Full Text] [Related]  

  • 57. Overexpression of the robA gene increases organic solvent tolerance and multiple antibiotic and heavy metal ion resistance in Escherichia coli.
    Nakajima H; Kobayashi K; Kobayashi M; Asako H; Aono R
    Appl Environ Microbiol; 1995 Jun; 61(6):2302-7. PubMed ID: 7793951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epidemiology of fluoroquinolone-resistant Escherichia coli among neutropenic patients.
    Kern WV
    Clin Infect Dis; 1998 Jul; 27(1):235-7. PubMed ID: 9675498
    [No Abstract]   [Full Text] [Related]  

  • 59. A close correlation between improvement of organic solvent tolerance levels and alteration of resistance toward low levels of multiple antibiotics in Escherichia coli.
    Aono R; Kobayashi M; Nakajima H; Kobayashi H
    Biosci Biotechnol Biochem; 1995 Feb; 59(2):213-8. PubMed ID: 7766020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of reduced fluoroquinolone susceptibility in Escherichia coli: a herald for emerging resistance.
    Chen FJ; McDonald LC; Ho M; Lo HJ
    J Antimicrob Chemother; 2001 Dec; 48(6):936-8. PubMed ID: 11733487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.